SIBIONICS Announced to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
LOS ANGELES, Feb. 18, 2024 /PRNewswire/ -- SIBIONICS, the world's third-largest Continuous Glucose Monitoring (CGM) System brand, announced the company will be exhibiting at the International Fair of New Technologies in Diabetes at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy on 6-9 March 2024. The company will showcase its latest CGM solutions for diabetes management at Booth No.15 at the conference. According to SIBIONICS, it has collaborated with over 1,800 hospitals on integrating their CGM for inpatient treatment, benefiting over 850,000 individuals worldwide in managing diabetes. SIBIONICS is constructing an automated production line with an annual capacity of 18 million CGM sets, expected to be completed within 2024.
- LOS ANGELES, Feb. 18, 2024 /PRNewswire/ -- SIBIONICS, the world's third-largest Continuous Glucose Monitoring (CGM) System brand, announced the company will be exhibiting at the International Fair of New Technologies in Diabetes at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy on 6-9 March 2024.
- The company will showcase its latest CGM solutions for diabetes management at Booth No.15 at the conference.
- According to SIBIONICS, it has collaborated with over 1,800 hospitals on integrating their CGM for inpatient treatment, benefiting over 850,000 individuals worldwide in managing diabetes.
- SIBIONICS is constructing an automated production line with an annual capacity of 18 million CGM sets, expected to be completed within 2024.